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Pancreatic insufficiency (PI) when left untreated results in a state of malnutrition due to an inability to absorb
nutrients. Frequently, PI is diagnosed as part of a larger clinical presentation in cystic fibrosis or Shwachman–Diamond
syndrome. In this study, a mouse model for isolated exocrine PI was identified in a mouse line generated by a
transgene insertion. The trait is inherited in an autosomal recessive pattern, and homozygous animals are growth
retarded, have abnormal immunity, and have reduced life span. Mice with the disease locus, named pequen ˜o (pq),
exhibit progressive apoptosis of pancreatic acinar cells with severe exocrine acinar cell loss by 8 wk of age, while the
islets and ductal tissue persist. The mutation in pq/pq mice results from a random transgene insertion. Molecular
characterization of the transgene insertion site by fluorescent in situ hybridization and genomic deletion mapping
identified an approximately 210-kb deletion on Chromosome 3, deleting two genes. One of these genes, Serpini2,
encodes a protein that is a member of the serpin family of protease inhibitors. Reintroduction of only the Serpini2 gene
by bacterial artificial chromosome transgenic complementation corrected the acinar cell defect as well as body weight
and immune phenotypes, showing that deletion of Serpini2 causes the pequen ˜o phenotype. Dietary supplementation
of pancreatic enzymes also corrected body size, body weight, and immunodeficiency, and increased the life span of
Serpini2-deficient mice, despite continued acinar cell loss. To our knowledge, this study describes the first
characterized genetic animal model for isolated PI. Genetic complementation of the transgene insertion mutant
demonstrates that Serpini2 deficiency directly results in the acinar cell apoptosis, malabsorption, and malnutrition
observed in pq/pq mice. The rescue of growth retardation, immunodeficiency, and mortality by either Serpini2 bacterial
artificial chromosome transgenic expression or by pancreatic enzyme supplementation demonstrates that these
phenotypes are secondary to malnutrition in pq/pq mice.
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Introduction
The ability to ectopically express novel genes in the mouse
genome via introduction of transgenic sequences has proved
to be a valuable tool in the study of mammalian development
and disease. However, in approximately 5% of the transgenic
lines produced, an insertional mutation at the genomic
integration locus also occurs [1]. Often the insertion of the
transgene is accompanied by a loss of surrounding genomic
sequences and, dependent on the location of nearby coding
and regulatory sequences, will produce an observable
phenotype. We have been able to take advantage of such a
transgene insertion/deletion event to identify and character-
ize a mouse model of pancreatic insufﬁciency (PI).
PI or a lack of pancreatic enzymes can lead to malab-
sorption due to an inability to digest and absorb nutrients.
The most common genetic disorder that exhibits PI is cystic
ﬁbrosis (CF), as 95% of patients with CF have pancreatic
acinar cell loss, with fatty cell replacement and interstitial
ﬁbrosis [2]. A second example of a syndrome that involves PI
is the Shwachman–Diamond syndrome (SDS). Patients
present with PI due to pancreatic acinar cell loss, but also
have clinical manifestations of short stature, neutropenia,
pancytopenia and predisposition to acute myelogenous
leukemia [3].
Animal models of acute PI have been created by inducing
pancreatic acinar cell apoptosis, either by administration of
the synthetic cholecystokinin analog caerulein [4] or by
physical blockage of the pancreas by ductal ligation [5].
However, deﬁned genetic animal models of PI have been
lacking. Only recently has a genetic model for an inbred CF
mouse been described that recapitulates pancreas involve-
ment of the disorder; however, this animal also manifests
other features of CF [6].
In this paper we describe a new mouse model for exocrine
PI that arose serendipitously in a line of mice carrying a
transgene insertion. This insertion event resulted in a
genomic deletion of the gene encoding the protease inhibitor
SERPINI2/ PANCPIN. The mutant allele, termed pequen ˜o
(which is the Spanish word for ‘‘small’’), is characterized by
severe exocrine acinar cell loss at 8 wk of age, while islets and
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autosomal recessive pattern, and untreated homozygotes are
malnourished, with a body weight one-third smaller than
control littermates. Secondary to the malnutrition, these
animals also have compromised immunity and a reduced life
span. Administration of pancreatic enzyme diet supplemen-
tation is sufﬁcient to reverse the effects of malnutrition in pq/
pq animals, counteracting the growth defects, decreased
viability, and immunodeﬁciency.
Results
Identification and Pathology of the Pequen ˜o Mouse Line
In offspring of a p3pTVA-B line of transgenic mice that
were bred to homozygosity, we observed runted mice with a
reduced viability phenotype that we called pequen ˜o (Figure
1A). Line p3pTVA-B was one of ﬁve independent transgenic
mouse lines generated using the Pax3 promoter to drive
expression of the avian retroviral receptor tv-a [7]. The four
other lines generated did not produce the pequen ˜o pheno-
type, suggesting that it was the site of transgene insertion that
caused the phenotype. Analyses of 34 progeny resulting from
the intercross of two obligate heterozygous mice demon-
strated that 24 transgenic offspring (71%) were produced, in
line with the expected Mendelian ratio. Six of the transgene-
positive mice (6/34, 17.6%) were signiﬁcantly smaller at
weaning, suggesting that they were homozygous for a
recessive mutation. Fluorescent in situ hybridization (FISH)
analyses of metaphase spreads from three pequen ˜o animals
using the p3pTVA construct as a probe were performed. All
three mice were homozygous for the transgene insertion on
mouse Chromosome 3 (data not shown). We concluded that
the pequen ˜o phenotype is due to a homozygous mutation (pq/
pq) that is linked to the transgene insertion and that the
phenotype is inherited in an autosomal recessive pattern, as
the heterozygotes had no apparent manifestations.
The pq/pq mice were on average one-third the weight of
wild-type littermates (Figure 1B) and produced a gray-
colored stool. Pathological assessment at 8 wk of age revealed
that the spleen and thymus were dramatically reduced in size
and the pancreas was abnormal by histological analyses of
affected animals when compared to unaffected littermates.
Gross skeletal abnormalities were not visible by X-ray or
skeletal preparation (data not shown). The thymus of
homozygous mutants (n ¼ 6) were about 4-fold smaller than
wild-type littermates (n ¼ 6) (2.90% versus 11.44% thymus/
brain weight; p , 2.5 3 10
 5). Similar results were observed
for the spleen (4.05% versus 16.7% spleen/brain weight; p ,
9.7 3 10
 7). Histological examination of the endocrine
pancreas for pq/pq mice revealed that islets and ductal tissue
appeared normal. Analysis of the exocrine pancreas showed a
striking loss of acinar cells (Figure 1). Histological evaluation
of the pancreas of younger animals at 1 wk of age showed
abnormal acinar cells that contained fewer zymogen granules
(ZGs) than those of littermate controls (Figure 1G and 1H).
However, by 3 wk of age pq/pq animals had only about one-half
the number of the pancreatic acinar cells when compared to
wild-type, despite the normal appearance of ductal and
endocrine islet cells (Figure 1F). This observation indicated
that extensive acinar cell loss was occurring between 1 and 3
wk of age in pq/pq animals.
Further analyses of the pancreas from 1-wk-old pq/pq
animals by electron microscopy revealed a reduction in size
and number of dense ZGs in the cytoplasm of the pq/pq acinar
cells and a lack of dense material within the ductal network
(Figure 2). In contrast, the pancreas of wild-type littermates
contained many ZGs, and electron-dense material represent-
ing large quantities of enzymes is found in the pancreatic
ducts (Figure 2A). Additionally, many pq/pq acinar cells were
found to exhibit hallmark features of cells undergoing
apoptosis. These acinar cells were smaller than adjacent cells
and contained compact cytoplasmic organelles, condensed
nuclear chromatin, and concentrically whirled bodies of
rough endoplasmic reticulum (Figure 2B–2D). In addition,
these acinar cells were observed being phagocytosed by
neighboring epithelial cells while some were sloughed directly
into the ductal lumina (Figure 2B–2D) [8]. As a second
independent method of assessing apoptosis, pancreatic tissue
was analyzed for DNA fragmentation using terminal deoxy-
nucleotidyl transferase biotin–dUTP nick end labeling
(TUNEL) staining. Pancreas sections from two animals in
each group (wild-type and pq/pq) were counted for TUNEL
staining in 12 independent, randomly selected ﬁelds (Figure
2E and 2F). The number of TUNEL-positive cells for pq/pq
animals (mean counts of 7.2 and 4.9 cells per ﬁeld) was
signiﬁcantly increased when compared to that of the wild-
type (0.33 and 0.25 cells per ﬁeld). Analyses of the four pair-
wise comparisons were statistically signiﬁcant (p , 0.01).
Taken together, these results are consistent with apoptosis as
the major cause of acinar cell loss.
To test the hypothesis that growth failure is caused by PI,
pq/pq animals were treated with a dietary supplementation of
pancreatic enzymes in addition to a normal diet and assessed
for correction of the malnutrition (Figure 3). Animals
supplemented with a pancreatic enzyme diet were monitored
for size, weight, and viability. Treated pq/pq mice gained both
weight and length when compared with untreated pq/pq
animals (Figure 3A and 3B). As expected, the enzyme
supplement did not correct the acinar cell deﬁciency (Figure
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Synopsis
Pancreatic insufficiency is defined by the inability to digest and
absorb nutrients due to the loss of pancreatic enzyme function or
loss of the acinar cells that produce the enzymes. In this manuscript
the authors have described a mouse model of pancreatic
insufficiency characterized by the specific loss of pancreatic acinar
cells. This specific acinar cell loss results in mice that are unable to
digest and absorb nutrients from the diet, stunting the animal’s
growth and giving rise to immunological anomalies. The authors
have identified a serendipitous transgene insertion/deletion encom-
passing the mouse Serpini2 gene locus as the source of the
phenotypes observed. Reintroduction of the Serpini2 gene, a
member of the serpin family of serine cysteine protease inhibitors,
by bacterial artificial chromosome complementation corrects the
pancreatic and immunological phenotypes of the disorder, confirm-
ing Serpini2 as the responsible gene. Reintroduction of pancreatic
enzymes through diet supplementation is also capable of correcting
the reduction in size and weight, reduction in viability, and
immunological deficiencies, indicating that these phenotypes are
secondary to malnutrition alone. This work provides a new mouse
model for investigation of malnutrition/malabsorption due to
pancreatic insufficiency and identifies a novel function for the
serpin family member Serpini2.3G). We conclude that the PI alone was responsible for the
growth retardation in pq/pq mice (Figure 3).
Identification of the Gene Responsible for the Pequen ˜o
Phenotype
To reﬁne the location of the transgene insertion site in
pequen ˜o mice, the p3pTVA transgene was hybridized to
heterozygous pq/þ chromosome spreads in combination with
bacterial artiﬁcial chromosomes (BACs) spanning Chromo-
some 3 using multicolor FISH. BACs spanning 52,290,000–
85,000,000 bp of Chromosome 3 were identiﬁed with NCBI
Map Viewer (http://www.ncbi.nlm.nih.gov/mapview/) mouse
build 31, and obtained from Children’s Hospital Oakland
Research Institute (http://www.chori.org/bacpac). This analysis
showed that the BAC clones RP23-388I15 and RP23-296I12
ﬂanked the p3pTVA transgene insertion and mapped the
insertion to a 2.3-MB region (Figure 4). This region contained
four genes of known function and several putative genes
represented by expressed sequence tags and/or gene pre-
diction algorithms (Figure 4B). One candidate gene in the
region, Serpini2, a serpin protein family member, is predicted
to be a serine-cysteine protease inhibitor. In addition,
Serpini2 has been shown to be expressed at high levels in
pancreas and adipose tissue [9,10], making it an excellent
candidate gene for the pequen ˜o phenotype.
The genomic draft sequence from the mouse February
2003 freeze build at the University of California at Santa Cruz
(http://genome.ucsc.edu/cgi-bin/hgGateway) was used to de-
sign primers within the Serpini2 gene and to the ﬂanking
genomic DNA (Figure 4B; Table S1). PCR analysis established
that the transgene insertion caused in an approximately 210-
kb genomic deletion at the locus, which included the entire
Serpini2 gene and continued distally to include several 39
exons of Ensembl-predicted novel gene transcript sequences
ENSMUST00000062199.1 (E-62199.1) and EN-
SMUST00000038943.1 (E-38943.1) (Figure 4B). The size and
location of the deletion established the possibility that the
pequen ˜o phenotype could be a recessively inherited con-
tiguous gene syndrome.
Figure 1. Acinar Cell Loss in pequen ˜o Mice
(A) Size of pq/pq mice in relation to wild-type and heterozygous littermates at 8 wk of age.
(B) Average weight of n ¼ 6 males for each genotype over a 32-wk period.
(C–H) Pancreas hematoxylin and eosin histological analyses were performed on 8-wk-old (C, D, and E), 3-wk-old (F), and 1-wk-old (G and H) mice. Wild-
type (þ,þ) acinar cells (C) and heterozygous (pq/þ) acinar cells (D) at 8 wk of age were morphologically normal. This is in contrast to homozygous (pq/pq)
animals at 8 wk of age (E) and 3 wk of age (F), where there is a severe loss of exocrine pancreatic acinar cells while duct cells and islet cells (arrow) are
normal. Acinar cells are present in pancreas samples from 1-wk-old pq/pq mice (H), but the cells are smaller and show reduced cytosolic volume when
compared to wild-type littermates (G). Bar represents 25 lm.
DOI: 10.1371/journal.pgen.0010038.g001
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gene in pancreas and adipose tissue as well as its proposed
function as a serine protease inhibitor suggested that deletion
of the Serpini2 locus alone caused the pequen ˜o phenotype. An
alternative explanation was that deletion of the two Ensem-
ble-predicted transcript sequences E-62199.1 and E-38943.1
contributed to the phenotype. Sequence analysis of the
predicted exons for E-62199.1/E-38943.1 suggested they are a
single gene and an ortholog of the human locus Unigene
cluster Hs.376728. The human gene sequence and predicted
mouse gene sequences are identical in exon–intron structure
and are 75% identical at the amino acid level. The pequen ˜o
deletion includes the entire Serpini2 gene locus and exons 14
Figure 2. Electron Microscopy Shows pequen ˜o Acinar Cells Are Present
but Undergoing Apoptosis at 1 Wk of Age
(A) Wild-type acinar cells have normal cellular morphology and
contained abundant numbers of ZGs (seen as black circular vesicles
containing electron-dense material), and electron-dense material from
ZGs is present in the ductal lumen (white arrow).
(B–D) pq/pq mice have fewer and smaller ZGs and no dense material in
the ductal lumen (L) when compared to wild-type animals. A significant
number of acinar cells are undergoing apoptosis, as indicated by the
presence of cellular phagocytosis (C and D), rough endoplasmic
reticulum whirling bodies (B and C) (black arrows), and nuclear
condensation and fragmentation (D) (asterisk).
(E and F) TUNEL staining of 3-wk-old pancreas tissue from wild-type (E)
and pq/pq (F) mice indicates an increase in TUNEL-positive, red-fushcin-
staining cells in pq/pq mice as compared to wild-type.
L, lumen; N, nucleus; RER, rough endoplasmic reticulum. For (A–D) bar
represents 5 lm. For (E and F) bar represents 50 lm.
DOI: 10.1371/journal.pgen.0010038.g002
Figure 3. pequen ˜o Malnutrition Is Rescued by BAC Transgenic Expressing
Serpini2 Gene or Pancreatic Enzyme Diet Supplementation
(A–C) Treatment of pq/pq mice (blue) pharmacologically with daily
pancreatic enzyme diet supplement (purple) or genetically with BAC
150E1 transgene (green), rescues (A) size, (B) weight, and (C) animal
viability in comparison to wild-type mice (black). For (B) weight
measurements are averaged from n ¼ 6 males from each genotype.
(D–G) Hematoxylin and eosin staining of pancreas sections from 8-wk-
old mice. Wild-type mice (D) have normal pancreatic acinar cells present
and normal pancreatic morphology while in (E) pq/pq mice there is a loss
of acinar cells. In the BACþ; pq/pq mice (F), pancreas acinar cells are
present. The acinar cell loss in pq/pq mice treated with enzyme
supplementation (G) is the same as untreated pq/pq mice (A–C),
although diet supplementation is effective in combating the effects of
malnutrition. Bar represents 25 lm.
DOI: 10.1371/journal.pgen.0010038.g003
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Pancreatic Insufficiency in Serpini2 Null Miceto 17 of E-62199.1/E-38943.1, leaving the ﬁrst three exons
intact.
BAC Transgene Complementation Cross Rescues Pequen ˜o
Acinar Cell Defect
In order to dissect the role of Serpini2 and rule out the
predicted genes as candidates for pequen ˜o, we produced a
BAC transgenic line, 150E1, to perform Serpini2 complemen-
tation crosses with pequen ˜o mice. BAC RP23-150E1 was
selected using the University of California at Santa Cruz
February 2003 browser because it contained the entire intact
Serpini2 gene and 71 kb of the upstream promoter region, but
not a functional E-62199.1/E-38943.1 gene. BAC-positive
(BACþ) transgenic animals were crossed with pq/þ mice and
the resulting double heterozygous BACþ; pq/þ animals were
backcrossed to pq/þ animals. Animals were genotyped with
primers to the p3pTVA transgene, a deletion-speciﬁc primer
‘‘77kb’’ (within the genomic deletion, but outside of BAC
150E1), and BAC vector end-speciﬁc primers. Transgenic
BACþ; pq/pq animals were indistinguishable from BAC ; þ/þ
and BACþ; þ/þ animals by size, weight and viability (see Fig-
ure 3A–3C). RT-PCR from pancreas RNA obtained from wild-
type, BAC ; pq/pq null, and BACþ; pq/pq BAC-complemented
animals was performed. The results demonstrated that
Serpini2 is not expressed in BAC ; pq/pq null animals and that
the BAC transgene in BACþ; pq/pq animals restored expres-
sion of Serpini2 in pancreas (data not shown). Histological
analysis of BACþ; pq/pq animals revealed they had normal
acinar cells, showing that Serpini2 expression alone corrected
the acinar cell defect phenotype (Figure 3D–3F). We conclude
that deletion of the Serpini2 gene, and not E-62199.1/E-
38943.1, causes the pequen ˜o phenotype of acinar cell loss
leading to PI and subsequent growth retardation due to
malabsorption and malnutrition.
Immune Cell Defects in pq/pq Mice
The pq/pq mice without pancreatic diet supplementation
exhibited decreased life span (typically 2–7 mo compared to
over 1 y for normal mice). Interestingly, when pq/pq mice
without pancreatic diet supplementation were housed in
sterile cages with acidiﬁed water, their condition improved
and their life span increased compared to pq/pq animals
housed in standard conditions. This suggested that the pq/pq
mice had compromised immune function and infections were
contributing to the morbidity (data not shown). We therefore
sought to characterize the immune system of the pq/pq mice.
Analyses of lymphoid organs revealed that pq/pq mice had a
reduction in thymic, splenic, and bone marrow cellularity by
21 and 28 d after birth (Figure 5). In particular, spleens from
pq/pq mice at 3–4 wk of age showed a dramatic reduction in
the number of lymphocytes present, with T cell numbers
reduced approximately 5-fold and B cell numbers reduced
more than 10-fold. Thymocyte numbers were also severely
reduced (10- to 20-fold), suggesting that the decrease in
mature T cells resulted from reduced thymic output. Despite
the dramatic reduction in thymic size, pq/pq mice had a
normal thymocyte proﬁle, with cells progressing from the
most immature double negative (CD4
 8
 ) population to
double positive CD4
þ8
þ cells and both CD4 and CD8 single-
positive mature cells, with no clear block at any stage (Figure
6). In particular, the increase in the percentage of single-
positive CD4
þ and CD8
þ cells argues that the cells exhibit no
defects in selection and can progress to the most mature
stages of thymic development. These results suggested that
thymic development was not blocked per se, but that there
was reduced cell input or viability at multiple stages.
We also observed a defect in B cell development. B
lymphocytes develop in the bone marrow through distinct
stages characterized by differential expression of cell surface
markers and the ordered rearrangement of Ig heavy and light
chain gene segments [11,12]. Wild-type mice have populations
of B220
þsIgM
 pro- and pre-B cells in their bone marrow that
upregulate and express increasing levels of sIgM on their cell
surfaces as they develop into immature and mature B cells. In
contrast, pq/pq mice had fewer pro- and pre-B cells
(B220
þIgM
 ), and expression of IgM on immature cells was
lower, particularly at day 28 (see Figure 5B). Within the
B220
þsIgM
  fractions, the most immature pro-B cell frac-
tions, fractions A–C, are further deﬁned by expression of
CD43 (B220
þIgM
 CD43
þ) and differing expression of CD24
[13]. Fraction A is CD24
  and contains cells that ﬁrst appear
Figure 4. Pequen ˜o Phenotype Is the Result of a 210-kb Genomic Deletion
(A) FISH to interphase pq/þ chromosome spreads with a p3pTVA transgene probe (red) locates the transgene insertion on mouse Chromosome 3
between BACs RP23-338I15 (yellow) and RP23-296I12 (green).
(B) The genomic region defined by BAC FISH localization contained six known or predicted genes, one of which, Serpini2, is highly expressed in pancreas
and adipose tissue. PCR primer sets A–P (Table S1) were used to characterize and define the identified ;210-kb deletion, indicated by red dashed line.
PCR primer sets that correspond to known and predicted exon sequences are indicated by black vertical dashed lines. The genomic deletion
encompassed the entire Serpini2 gene locus and exons 4 to 17 of the predicted gene E-62199.1/E-38943.1.
DOI: 10.1371/journal.pgen.0010038.g004
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Fractions B (early pro-B cells) and C (late pro-B cells) now
express CD24 and initiate rearrangement at the IgH locus
(B220
þIgM
 CD43
þCD24
þ). Compared to wild-type, pq/pq pre-B
cells manifested a higher percentage of B220
þIgM
 CD43
þ
cells, indicative of a partial block in B cell development prior
to the pre-B cell stage. This block was more apparent as the
mice aged (compare day 28 to day 21, Figure 5B). Moreover,
within the CD43
þ fraction, pq/pq pro-B cells expressed lower
levels of CD24, demonstrating that this block occurred
between the pre-proB and early pro-B cell stage. Similarly,
in the spleen, reduced numbers of the most immature
population of B cells (IgM
þIgD
 ) were observed (Figure 5C),
arguing that there was reduced production of B cells in the
bone marrow.
Pancreatic Diet Supplementation and BAC Transgene
Rescues Immune System Defects
To determine whether the PI and subsequent malnourished
state alone were contributing to the impaired immune system
or whether there was an intrinsic defect in pq/pq lymphocytes
due to the lack of SERPINI2, we sought to determine how the
pq/pq mice would respond to dietetic supplementation with
pancreatic enzymes in contrast to BACþ; pq/pq and pq/pq
untreated animals. The pancreatic enzyme replacement
therapy restored immune cell numbers in the pq/pq mice,
suggesting immune system defects were secondary to malnu-
trition. Similarly, BACþ; pq/pq transgenic mice were also able
to complement immune system defects. At 4 wk of age,
enzyme supplementation resulted in a partial rescue, while
animals with the BAC transgene were indistinguishable from
wild-type animals with respect to cellularity of the spleen,
thymus, and bone marrow and the numbers of mature T and
B cells within the spleen (see Figure 6A). Moreover, both the
diet supplementation and the BAC transgene insertion
complemented bone marrow differentiation defects. pq/pq
mice with either pancreatic enzyme diet supplementation or
the BAC transgene had an increased B220
þIgM
  fraction and
normalized development of IgM
þ immature B cells and the
percentage of early progenitor B cells, as deﬁned by CD43
and CD24, when compared to pq/pq animals without either
enzyme supplementation or BAC transgene introduction
(Figure 6C). Splenic B cell proﬁles were also normalized, with
increased percentages of early newly emigrated B cells (Figure
6D) in enzyme-treated and BAC transgenic pq/pq animals.
Thus, the immune defects in pq/pq mice appear to be the in
large part secondary to pancreatic exocrine deﬁciency, which
leads to malnourishment caused by malabsorption.
Discussion
We have identiﬁed a mutant with PI caused by a deletion of
the protease inhibitor Serpini2. This phenotype (pequen ˜o) is
inherited in an autosomal recessive pattern and is to our
knowledge the ﬁrst published mouse mutant to genetically
model PI. The mutation, caused by a transgene insertion, led
to an approximately 210-kb genomic deletion that completely
removes the Serpini2 gene and a portion of the predicted gene
E-62199.1/E-38943.1. Reintroduction of the Serpini2 gene
alone by BAC complementation corrected the acinar cell
defect and improved immune function, demonstrating that
deletion of the Serpini2 gene is the primary genetic cause of
the pequen ˜o mouse phenotype.
Serpini2 was initially identiﬁed and implicated as a
potential tumor suppressor gene because it was downregu-
lated in pancreatic cancer cell lines when compared to
normal pancreas [9]. Serpini2 is also known as MEPI, a gene
expressed in normal breast myoepithelial cells, but not in
malignant breast carcinoma cells [14]. We did not observe any
overt phenotype in the pequen ˜o mice with regard to mammary
gland development/function. Female pq/pq mice that had been
maintained on a pancreatic enzyme diet supplementation
were able to rear litters of 8–10 pups with no difﬁculty. It is
possible that loss of expression in mammary tissue does not
affect mice mammary gland function. Alternatively, there is
the potential that another serpin family member may be
compensating for the loss of Serpini2 activity, as has
previously been observed for loss of Serpinb6 function
resulting in upregulation of Serpinb1 expression [15].
SERPINI2 is a member of the serpin superfamily of
proteins that have been implicated in a variety of functions
including blood coagulation, angiogenesis, inﬂammation, and
programmed cell death [16]. In humans, 33 serpins have been
identiﬁed [17]. These proteins are further subdivided into two
classes, inhibitory and non-inhibitory. The former group,
which includes SERPINI2, is characterized by conformational
structure changes that allow for formation of covalent acyl-
enzyme intermediates with the proteins’ target protease, and
thus have been termed ‘‘suicide substrates’’ [18]. The target
substrates for SERPINI2 are unknown.
Further insight into the cellular location and function of
SERPINI2 has come from work with the rat homolog, ZG-46p.
SERPINI2/ZG-46p has been characterized in the pancreas,
located predominately in the Golgi and in ZGs [19], and was
isolated from ZG membranes [20]. ZGs in the acinar cells
contain inactive proenzyme precursors for digestive enzymes
including trypsin, amylase, chymotrypsin, and carboxypepti-
dase. Normal acinar cells produce large quantities of granules
that are transported from the trans-Golgi network to the
luminal side of the acinar cell and are then secreted to the
ductal lumen upon hormonal and neural signaling mecha-
nisms. The contents of the ZGs are transported via ducts to
the duodenum (pp. 429–430 of [21]), where these enzymes are
required for proper digestion and absorption of food.
Given the subcellular location of SERPINI2 in the Golgi
Figure 5. Decreased Lymphocyte Numbers and Impaired B cell Development in pequen ˜o Mice
(A) pequen ˜o mice exhibit a striking reduction in the cellularity of the thymus, spleen and bone marrow at days 21 and 28 of life (n ¼ 3).
(B) pequen ˜o mice show decreased early B cell progenitors in the bone marrow. Expression profiles of B220 and IgM on total lymphoid cells in bone
marrow are shown for wild-type (top row, percentage of B220
þIgM
 pro-/pre-B cell fraction are indicated). The B220
þIgM
 pro-/pre-B cell fraction (filled
arrow) was gated to analyze the developmental stages using CD43 (middle row). The B220
þIgM
 CD43
þ (less mature) fraction (open arrow) was then
gated on to analyze CD24 expression (bottom row). pq/pq mice exhibit an increase in the proportion of CD43
þCD24
  B cells, indicating a block in the
pre-/pro-B to early pro-B transition.
(C) Flow cytometric analysis of surface IgM
þ/IgD
  expression on B220
þ cells in the spleen indicates a decreased percentage of immature (IgM
þ/IgD
 )B
cells in the pequen ˜o mice.
DOI: 10.1371/journal.pgen.0010038.g005
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serine protease inhibitor, we hypothesize that SERPINI2 may
play a role in regulating the level of inactive zymogen
precursors. The importance of tight regulation of active
protease levels by protease inhibitors in the exocrine
pancreas is well documented. This regulation is demonstrated
by considering mutations in two genes that are mutated in
human hereditary pancreatitis: the cationic trypsinogen gene
PRSS1 and serine protease inhibitor Kazal type 1 (SPINK1). For a
small number of individuals with chronic PI, mutations in
either gene have been shown to alter this balance and lead to
autodigestion of tissue with inﬂammation [22,23]. However,
genetic animal models for these two genes are lacking.
It is also important to note that differences in the severity
of pancreatitis may be regulated by the type of cellular
response to the inﬂammation, whether apoptosis or necrosis.
In several models of PI, acinar cell apoptosis causes a less
severe pancreatitis phenotype [24–26], in contrast to the
more severe pancreatitis that has been documented with
acinar cell necrosis [25,27]. It is interesting to speculate that
other less severe alleles than the null allele present in the
pequen ˜o mouse model may not have severe apoptosis and may
demonstrate a pancreatitis phenotype similar to that ob-
served in patients with SPINK1 mutations.
Alternatively, SERPINI2 may function to allow proper
sorting and/or transport of ZGs from the Golgi to the ductal
lumen of the acinar cell. This hypothesis is consistent with the
observations made of the acinar cells of 1-wk-old pq/pq mice
that have yet to undergo apoptosis. In these acinar cells there
is a dramatic loss of ZGs present in the cell and the ZGs
appear smaller in size than those in wild-type and hetero-
zygous littermates. Further analysis is required to differ-
entiate these potential modes of action for SERPINI2.
It is clear that malnutrition is the primary cause of the
observed pequen ˜o phenotypes. The inability of pq/pq mice to
adequately digest and absorb food from a young age adversely
affects growth and immune system function. A large body of
evidence argues that malnutrition, stress-induced hormones,
and corticosteroids can adversely affect immune cell numbers
and survival [28]. In addition, leptin, a pleiotropic molecule
that regulates food intake and metabolic endocrine functions,
also plays a role in immune and inﬂammatory responses [29].
Although the defects we observed here do not completely
correlate with those associated with increased steroid
exposure in mice, most studies of steroid exposure have
examined short-term glucocorticoid exposure [30]. However,
over-expression of a glucocorticoid receptor in the thymus
produced results similar to ours, with reduced cellularity
observed at multiple stages of T cell development [31].
Similar long-term studies have not examined B cell numbers
or function. While we cannot rule out a direct effect of
SERPINI2 on lymphocytes, the improvement of immune
function by pancreatic diet supplementation strongly sug-
gests that these defects are secondary to malnutrition, which
could result in increased stress hormone and steroid
production, decreased leptin levels, and/or a lack of nutrients.
It is interesting that growth retardation, PI, and immuno-
deﬁciency are present in both the pequen ˜o mouse and the
human disorder SDS. The human disease is a rare and
clinically heterogeneous disorder that manifests PI, short
stature, lipidosis of the pancreas, neutropenia, pancytopenia,
and predisposition to acute myelogenous leukemia. Although
we have not observed neutropenia in the blood of pq/pq mice
(Figure S1; Table S2), it may be difﬁcult to compare
secondary immune defects in mouse and human, as effects
of malnutrition and stress hormones may differ between the
species. Nonetheless, the combination of PI and immune
defects in this mouse mutant is intriguing, given that several
recent studies indicate SDS may exhibit genetic heterogeneity
[32–34].
The most common mutation for SDS has been identiﬁed
and is a gene conversion caused by recombination of the
ubiquitously expressed SBDS gene with the pseudogene
SBDSP located 5.8 Mb away on Chromosome 7 [32]. The
SBDS protein is predicted to be an RNA-processing enzyme
based upon sequence homology to a yeast ortholog and
cluster analysis data from microarray experiments [32]. Given
the overlap in phenotypes of the pequen ˜o mice and genetic
heterogeneity predicted for patients with SDS, Serpini2 is a
candidate gene for analysis in the subset of patient samples in
which no mutation in the SBDS gene can be identiﬁed.
Materials and Methods
Pancreatic enzyme diet. The pancrezyme diet was provided as a
supplementation to normal mouse chow Rodent NIH-31 Auto18–4
(Ziegler, Gardeners, Pennsylvania, United States). The supplement
(Pancrezyme, Daniels Pharmaceuticals, St. Petersburg, Florida,
United States) was mixed with Transgenic Dough diet (Bio-Serv,
Frenchtown, New Jersey, United States) at a ratio of 0.9 g supplement/
50 g of transgenic dough. Five grams per animal of supplemented
transgenic dough mixture was provided once every 24 h.
FISH. Metaphase spreads were performed with standard air-drying
technique from blood collected from retro-orbital bleeds and mouse
spleens [35]. DNA was labeled by nick translation technique,
essentially as described by Pinkel et al. [36] and Lichter et al. [37]
with Spectrum Orange (Vysis, Downers Grove, Illinois, United States).
On each slide 200 ng of labeled probe was applied. Repeat sequences
were blocked with 103 excess Cot1 DNA, 10 ll of a hybridization
mixture containing the labeled DNA, 50% formamide, 23 SSC, and
10% dextran sulfate (pH 7) and were denatured at 75 8C for 10 min,
then incubated at 37 8C for 30 min. Slides were incubated for at least
1 h at 37 8Ci n2 3 SSC, then dehydrated with 2-min ethanol washes
(70%, 80%, and 90%). Slide denaturation was performed in 70%
formamide/23 SSC for 2 min, then dehydrated at  20 8C in 2-min
ethanol washes (70%, 80%, 90%, and 100%). Post-hybridization
washes were performed at 45 8C as follows: (1) 50% formamide and
23 SSC for 15 min, (2) 0.13 SSC for 10 min. Slides were
counterstained with DAPI-Antifade (250 ng/ul BM, Vector, Burlin-
game, California, United States).
Production of BAC transgenic mice. P3pTVA-transgenic mice were
generated as described [7]. For BAC complementation analysis,
fertilized oocytes obtained from matings of C57BL/6J mice were used
for pronuclear injection of RP23-150E1 BAC DNA. BAC DNA was
puriﬁed by CsCl gradient isolation and not linearized prior to
Figure 6. Pancreatic Enzyme Supplementation and BAC Transgenesis Rescue Lymphocyte Cells Numbers and Developmental Defects in pequen ˜o Mice
(A) pequen ˜o mice with either enzyme supplementation (pq/pq; diet) or a BAC transgenic (pq/pq; BAC) display increased cellularity of the thymus, spleen,
and bone marrow at day 28 of life (n ¼ 4).
(B–D) Pancreatic enzyme supplementation and the BAC transgenic rescue the developmental defects in the pequen ˜o mice. (B) CD4 and CD8 expression
profiles of the thymus. (C) Expression profiles of B220 and IgM on total lymphoid cells in bone marrow (top row). The B220
þIgM
 pro-/pre-B cell fraction
(filled arrow) was gated to analyze the developmental stages using CD43 (middle row). The B220
þIgM
 CD43
þ (less mature) fraction (open arrow) was
then gated on to analyze CD24 expression (bottom row). (D) Splenic expression profile analysis of surface IgM/IgD expression on B220
þ cells .
DOI: 10.1371/journal.pgen.0010038.g006
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were 0.5–0.75 lg/ul. A total of 69 pups were born, ﬁve of which were
positive for the BAC by PCR.
Histology and electron microscopy. Tissues evaluated by hematox-
ylin and eosin staining and light microscopy were ﬁxed in 10%
neutral buffered formalin routinely processed, embedded into
parafﬁn, sectioned at 5 lm thick, and stained with hematoxylin and
eosin, performed by Histoserve (Rockville, Maryland, United States).
Pancreas tissue evaluated by electron microscopy was ﬁxed in 2.5%
glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) overnight. The
tissue was washed with cacodylate buffer and postﬁxed with 1% OsO4
for 2 h. Tissue was washed again with 0.1 M cacodylate buffer, serially
dehydrated in ethanol and propylene oxide and embedded in
Eponate 12 resin (Ted Pella, Redding, California, United States).
Thin sections, approximately 80 nm, were obtained by utilizing the
Leica Ultracut-UCT ultramicrotome (Leica, Deerﬁeld, Illinois, United
States) and placed onto 400 mesh copper grids and stained with
saturated uranyl acetate in 50% methanol and then with lead citrate.
The grids were viewed in the Philips 410 electron microscope (FEI,
Hillsboro, Oregon, United States) at 80 kV and images were recorded
on Kodak (Rochester, New York, United States) SO-163 ﬁlm.
TUNEL staining. Pancreas tissue for TUNEL staining was ﬁxed in
4% paraformaldehyde, sectioned at 5 lm thick, with TUNEL staining
performed by Histoserve. Visualization of TUNEL-positive cells was
done using New Fushcin dye. Each of the results for the two wild-type
animals (mean counts of 0.33 and 0.25 per ﬁeld) was compared to
each of the two results for the pq/pq animals (mean counts of 7.2 and
4.9 per ﬁeld) in a Bonferroni multiple-comparison test (pp. 255–262
of [38]). Because the distributions had signiﬁcantly different standard
deviations, the test was repeated with the non-parametric Kruskal-
Wallis test followed by Dunn’s post test [38]. All four pair-wise
comparisons were statistically signiﬁcant at p , 0.01.
Cell preparation and ﬂow cytometry. Bone marrow cells were
obtained by injecting PBS containing 5% FCS through surgically
extracted femurs. Splenic cells and thymocytes were obtained by
dissociation of the tissue with a plastic mesh and rubber stopper from
a 3-ml syringe. All cells were treated with red blood cell lysis solution.
For ﬂow cytometric analysis, cells were blocked with normal mouse
serum and Fc block for 10 min, then stained with FITC-, PE-,
CyChrome-, or biotin-conjugated antibodies for 30 min. Biotin-
conjugated antibodies were dete c t e dw i t has e c o n d a r ys t a i n :
streptavidin-APC. Analysis was performed on a FACScan (Becton-
Dickinson, Palo Alto, California, United States) using Flowjo software.
The following monoclonal antibodies were obtained from BD
PharMingen (San Diego, California, United States): CD3, CD4, CD8,
B220, CD19, CD43, CD24, CD11b, GR-1, Ter119, DX5, and IgM.
Anti-IgD was purchased from Southern Biotechnology (Birmingham,
Alabama, United States).
Genotyping. PCR reactions used 13 Genamp PCR buffer, 2.5 mM
MgCl2, 0.2 mM dNTPs, 0.2 nM each primer, and 1 unit Amplitaq
(Applied Biosystems, Foster City, California, United States).
PCR conditions were 5 min. denaturation at 93 8C followed by
35 cycles of 93 8C for 30 sec, 58 8C for 30 sec, and 72 8C for
30 sec. BAC primers designed to ﬂanking arm sequences
were 3199R (CGCTGCAAAACGCTGACGGAACAGTAG) and
3670R (CTCAGCGTATGGTTGTCGCCGGATGTAT), and 11016F
(ATGGGCAAATATTATACGCAGGCGACAAG) and 11595R
(CGTATTAGCGGCCGCAAATTTATTAGAGCA). Primers within
the pequen ˜o deletion, but outside of BAC sequences were 77kbF
(CTTGCCTCATCAATGCTAGG) and 77kbR (GGATAAGTCTATCT-
GACTTC). Primers speciﬁc to transgene insertion were P3p39
(CTGGAGCCTGTGGACTTGGAT) and TVA Rout2 (CAGTGATCAG-
CATCCACATGC).
For primers used to characterize the pequen ˜o genomic deletion, see
Table S1.
Supporting Information
Figure S1. Detection of Neutrophils in the Bone Marrow of Wild-
Type and pq/pq Mice
(A) Flow cytometric analysis was conducted by gating on granulocytes
using forward versus side light scatter and GR-1and CD11b staining
in the bone marrow. Increased percentage of neutrophils in the bone
marrow of pq/pq mice is due to elevated percentage of GR-1lo CD11b
þ
immature neutrophils.
Found at DOI: 10.1371/journal.pgen.0010038.sg001 (696 KB PDF).
Table S1. Primers Sets Used to Deﬁne Genomic pequen ˜o Deletion
Found at DOI: 10.1371/journal.pgen.0010038.st001 (63 KB DOC).
Table S2. pequen ˜o Mice Show Increased Percentage of Neutrophils in
Blood
Found at DOI: 10.1371/journal.pgen.0010038.st002 (54 KB PDF).
Accession Numbers
The OMIM (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db¼OMIM)
accession numbers for the genes and gene products discussed in this
article are CF (602421) and SDS (260400).
The MGI (http://www.informatics.jax.org/) accession number for
Serpini2 is 1915181.
The Ensembl (http://www.ensembl.org) accession numbers for
the genes discussed in this article are PRSS1 (ENSG00000173636),
SPINK1 (ENSG00000164266), and E-62199.1/E-38943.1 (ENS-
MUSG00000058653).
The UniGene (http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?db¼unigene) accession number of the human ortholog of the
mouse gene Serpini2 discussed in this article is Hs.376728.
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